C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) A61K 31/435 (2006.01) A61K 31/495 (2006.01) A61K 31/53 (2006.01) A61K 31/675 (2006.01) C07D 519/00 (2006.01) C07F 9/6561 (2006.01)
Patent
CA 2195570
A class of novel indolizine-1-functional compounds and indolizine-3-functional compounds is disclosed together with the use of such indolizine compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of conditions such as septic shock. The compounds are indolizine-1-acetamides, indolizine-1-acetic acid hydrazides, indolizine-1- glyoxylamides, indolizine-3-acetamides, indolizine-3-acetic acid hydraxides, and indolizine-3-glyoxylamides.
L'invention porte sur de nouveaux composés fonctionnels de l'indolisine-1 et de l'indolisine-3 ainsi que leur mode d'utilisation en vue d'inhiber la libération d'acides gras sous l'action du sPLA2 dans le cadre du traitement d'états tels que le choc septique. Lesdits composés sont: des acétamides de l'indolisine-1, des hydracides de l'acide acétique de l'indolisine-1, des indolisine-1 glyoxylamides, des acétamides de l'indolisine-3, des hydrazides de l'acide acétique de l'indolisine-3, et des indolisine-3 glyoxylamides.
Dillard Robert Delane
Hagishita Sanji
Ohtani Mitsuaki
Eli Lilly And Company
Gowling Lafleur Henderson Llp
Shionogi & Co. Ltd.
LandOfFree
Indolizine spla2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indolizine spla2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indolizine spla2 inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1545712